EQT has announced the acquisition of Swedish biotech company Mabtech in what partner Isabel de Paoli told PE Hub Europe was a “perfect fit” for the private equity firm’s new Healthcare Growth Strategy. EQT plans to help Mabtech grow its commercial operations and product portfolio and expand internationally, including in the US, de Paoli added.
EQT finds ‘perfect fit’ for new strategy with Mabtech acquisition
The private equity firm aims to grow the Swedish biotech company’s footprint in the US, partner Isabel de Paoli told PE Hub Europe.
